Last updated on 18 May 2023
Owner Info
APIRx Pharmaceutical USA, LLC Limited Liability Company (Delaware)
18 E. 50th Street
5th Fl., Suite B, New York, New York, 10022 UNITED STATES OF AMERICA
Serial Number
2217412 filed on 8 Oct 2021
Correspondent
Davies Collison Cave Pty Ltd
Level 4,
7 Macquarie Place,
Sydney, NSW, 2000 AUSTRALIA
2217412
8 Oct 2021
8 Oct 2031
WORD
25 May 2021
US
Status Date | Action Taken |
---|---|
18th May 2023 | Customer Amendment Made correspondence sent |
18th May 2023 | Customer Amendment Made correspondence sent |
18th May 2023 | Amendment to Address for Service Requested |
11th Jan 2022 | IP Right Registered correspondence sent |
11th Jan 2022 | IP Right Registration Published |
11th Jan 2022 | Status change to Registered/Protected |
26th Oct 2021 | Application Accepted correspondence sent |
26th Oct 2021 | IP Right has been Examined |
26th Oct 2021 | IP Right Acceptance Published |
22nd Oct 2021 | Early Acceptance Notice correspondence sent |